Debut Plus

₹2,529.4

▲ +64.34 +2.61%

17 Jul 2026

NSE Listed · Pharmaceuticals

Gland Pharma Limited (GLAND)

Volume: 8,09,358Avg Vol 1W: 3,35,166Avg Vol 1M: 3,21,77652W Range:₹1,573.6₹2,573.5
NSE BSE www.glandpharma.com
Key Ratios
Checked just now
Market Cap₹41,725 Cr
Current Price₹2,529.4
Previous Close₹2,465.06
High / Low (52w)₹2,573.5 / ₹1,573.6
Volume8,09,358
Avg Vol (1W)3,35,166
Avg Vol (1M)3,21,776
Stock P/E113.63
Book Value₹627.91
Dividend Yield79%
ROE9.92%
ROA8.21%
Revenue (TTM)—
Revenue Growth-0.85%
Profit Margin15.98%
Total Debt₹78 Cr
Shares Outstanding16 Cr
Face Value₹1
EPS (TTM)₹63.29
P/B4.03
Debt / Equity0.04
50 DMA₹2,373.66
200 DMA₹1,998.98
Day change+2.61%
Price Chart
₹2,529.4▲ 41.23% · 1Y
₹2551₹159771.3L
2025-11-24
2026-07-16

20-day avg volume: 3.3L shares

Pros
  • Pays a dividend yield of 79.0%.
  • Company is almost debt-free.
Cons
  • Stock trades at a high P/E of 114.
Quarterly Results
MetricJun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Revenue₹1,402 Cr₹1,406 Cr₹1,384 Cr₹1,425 Cr₹1,506 Cr₹1,487 Cr₹1,695 Cr₹1,743 Cr
EBITDA₹224 Cr₹263 Cr₹322 Cr₹296 Cr₹324 Cr₹292 Cr₹390 Cr₹516 Cr
Net Profit₹144 Cr₹164 Cr₹205 Cr₹187 Cr₹215 Cr₹184 Cr₹261 Cr₹367 Cr
EPS————————
Profit & Loss (Annual)
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Revenue₹2,772 Cr₹3,598 Cr₹4,625 Cr₹3,865 Cr₹5,835 Cr₹5,830 Cr
EBITDA₹1,000 Cr₹1,338 Cr₹1,624 Cr₹1,118 Cr₹1,159 Cr₹1,105 Cr
Net Profit₹773 Cr₹997 Cr₹1,212 Cr₹781 Cr₹772 Cr₹699 Cr
EPS49.8862.9973.6447.4346.8942.4
Balance Sheet
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Total Assets₹4,086 Cr₹6,496 Cr₹7,834 Cr₹8,778 Cr₹10,661 Cr₹11,225 Cr
Total Liabilities₹440 Cr₹593 Cr₹676 Cr₹819 Cr₹1,937 Cr₹2,074 Cr
Equity₹3,646 Cr₹5,903 Cr₹7,158 Cr₹7,959 Cr₹8,724 Cr₹9,151 Cr
Total Debt——————
Cash Flow
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating₹945 Cr₹916 Cr₹1,197 Cr₹675 Cr₹1,303 Cr₹1,269 Cr
Investing₹-766 Cr₹-1,524 Cr₹-1,003 Cr₹1,208 Cr₹-1,757 Cr₹1,705 Cr
Financing₹-7 Cr₹1,238 Cr₹35 Cr₹15 Cr₹-799 Cr₹-433 Cr
Free Cash Flow₹945 Cr₹916 Cr₹1,197 Cr₹675 Cr₹1,303 Cr₹1,269 Cr
Shareholding
Promoter 51.83% Institutions 40.65% Public 7.52%
Efficiency & Working Capital
ROCE14%
Interest Coverage26.3
Dividend Payout—
Debtor Days99 d
Inventory Days110 d
Payable Days53 d
Cash Conversion Cycle155 d
Working Capital Days208 d
Shareholding Details

As of 2026-03-31

Promoter51.8%
FII7.3%
DII33.4%
Institutions40.7%
Public7.5%
Promoter Pledge0%
No. of Shareholders91,500
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodJun 2023Sept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Promoters57.9%57.9%57.9%57.9%51.8%51.8%51.8%51.8%51.8%51.8%51.8%51.8%
FIIs2.8%4.9%4%3.6%6.9%4.5%5%6.9%7.4%7.9%7.6%7.3%
DIIs23.4%22.4%23.1%25.2%32.8%35.4%34.8%33.3%32.9%32.6%33%33.4%
Public16%14.8%15%13.3%8.5%8.3%8.3%8%7.9%7.6%7.6%7.5%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders1,81,7471,61,6271,36,0211,22,3751,22,6651,22,3581,21,0751,13,7881,10,67197,15194,57891,500
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202503————
Major Shareholders (>1%)
NameCategoryStakeShares
Fosun Pharma Industrial Pte. LtdShareholding of Promoter and Promoter Group51.8%8.54 Cr
Mirae Asset Large & Midcap FundPublic Shareholding6.9%1.14 Cr
Hdfc Mutual Fund - Hdfc Mid-cap FundPublic Shareholding6.4%1.05 Cr
Nippon Life India Trustee Ltd- A/c Nippon India Growth Mid Cap FundPublic Shareholding5%83,01,684
Sbi Large & Midcap FundPublic Shareholding3.3%54,13,265
Icici Prudential India Opportunities FundPublic Shareholding3.1%50,97,987
Dsp Small Cap FundPublic Shareholding1.7%27,18,766
Government Pension Fund GlobalPublic Shareholding1.4%22,36,174
Uti-flexi Cap FundPublic Shareholding1.2%20,13,316
Ample Up LimitedShareholding of Promoter and Promoter Group0%10
Fosun Industrial Co LimitedShareholding of Promoter and Promoter Group0%10
Lustrous Star LimitedShareholding of Promoter and Promoter Group0%10
Regal Gesture LimitedShareholding of Promoter and Promoter Group0%10
Promoter Pledges
HolderPledged Shares% of HoldingAs of
Fosun Pharma Industrial Pte. Ltd00%2026-03-31
Ample Up Limited00%2026-03-31
Fosun Industrial Co Limited00%2026-03-31
Lustrous Star Limited00%2026-03-31
Regal Gesture Limited00%2026-03-31
Mirae Asset Large & Midcap Fund00%2026-03-31
Hdfc Mutual Fund - Hdfc Mid-cap Fund00%2026-03-31
Nippon Life India Trustee Ltd- A/c Nippon India Growth Mid Cap Fund00%2026-03-31
Sbi Large & Midcap Fund00%2026-03-31
Icici Prudential India Opportunities Fund00%2026-03-31
Dsp Small Cap Fund00%2026-03-31
Uti-flexi Cap Fund00%2026-03-31
Board of Directors
NameDesignationYear
SRINIVAS SADUChairman / Executive Director / MD / CEO2025
UDO JAHANNES VETTERIndependent Non Exe. Director2025
ESSAJI GOOLAM VAHANVATIIndependent Non Exe. Director2025
Jia Ai (Allen) ZhangNon-Exec & Non-Independent Dir2025
Naina Lal KidwaiIndependent Non Exe. Director2025
Wenjie ZhangNon-Exec & Non-Independent Dir2025
Wei HuangNon-Exec & Non-Independent Dir2025
SAMPATH KUMAR PALLERLAMUDICS / Compliance Officer / Vice President2025
William Robert KellerAdditional Director2025
Segments — Product
SegmentRevenueShare
Pharmaceuticals₹0 Cr—
Segments — Geography
RegionRevenueShare
USA₹2,128 Cr61.5%
India₹556 Cr16.1%
Europe₹151 Cr4.4%
Canada₹66 Cr1.9%
Australia₹16 Cr0.5%
Rest Of The World₹546 Cr15.8%
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2025₹1501616
Corporate Actions
TypeDateValueRemark
forthcoming2026-08-11Dividend (20/- per share)Final
dividend2025-08-14₹18 (1800%)Final
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
202517,8910015017,906
20254040000404
20252,225001502,240
Insider / Designated-Person Trades

30 recent disclosure(s)

Jayatheerth AdvaniDisposal · 1,000
K RAGHURAMACHANDRA RAODisposal · 1,000
K RAGHURAMACHANDRA RAODisposal · 1,000
Jayatheerth AdvaniDisposal · 500
SREENIVASA RAO SURAGAMDisposal · 500
SREENIVASA RAO SURAGAMDisposal · 1,000
Substantial Acquisitions (SAST)

11 disclosure(s)

Market11/04/2025 · 4,00,020
Market24/06/2024 · 60,000
Market19/06/2024 · 99,00,000
Market27/05/2024 · 5,85,086
Market09/04/2024 · 33,75,525
Market09/04/2024 · 61,65,486
Company Information
Incorporated1978
ChairmanSRINIVAS SADU
AuditorDeloitte Haskins & Sells
Investor Email[email protected]
🌐 www.glandpharma.com ↗

📍 Sy No 143-148 150&151 Nr Gandi, X Roads D P Pally Dundigal, Hyderabad, Telangana, 500043

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

Guj Ind Pow Co. Ltd.Giriraj Civil Devp Ltd.Grover Jewells LimitedGK Energy LimitedGujarat Kidney N Sup Sp LimitedGKW LimitedGlaxoSmithKline Pharma Ltd.Glenmark PharmaceuticalsGujarat Lease Financing LimitedGlobal Education LimitedGlobale Tessile LimitedGlobal Pet Industries Ltd.All “G” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search